14,500 Shares in Enhabit, Inc. (NYSE:EHAB) Purchased by OLD National Bancorp IN
14,500 Shares in Enhabit, Inc. (NYSE:EHAB) Purchased by OLD National Bancorp IN
OLD National Bancorp IN purchased a new position in shares of Enhabit, Inc. (NYSE:EHAB – Get Rating) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 14,500 shares of the company's stock, valued at approximately $204,000.
根据Old National Bancorp IN最近提交给美国证券交易委员会的13F文件，该公司在第三季度购买了EnHabit，Inc.(纽约证券交易所代码：EHAB-GET Rating)的新股票头寸。该基金购买了14,500股该公司股票，价值约204,000美元。
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Retirement Systems of Alabama acquired a new position in Enhabit during the third quarter worth about $982,000. Landscape Capital Management L.L.C. acquired a new position in Enhabit during the third quarter worth about $220,000. Foster & Motley Inc. acquired a new position in Enhabit during the third quarter worth about $153,000. Maryland State Retirement & Pension System acquired a new position in Enhabit during the third quarter worth about $340,000. Finally, BCR Wealth Strategies LLC purchased a new position in Enhabit during the third quarter worth about $78,000. 95.55% of the stock is currently owned by institutional investors and hedge funds.
其他机构投资者和对冲基金最近也买卖了该公司的股票。阿拉巴马州退休系统公司在第三季度收购了EnHabit的一个新头寸，价值约98.2万美元。景观资本管理公司在第三季度收购了EnHabit的一个新头寸，价值约22万美元。Foster&Motley Inc.在第三季度收购了EnHabit的一个新头寸，价值约15.3万美元。马里兰州退休和养老金系统在第三季度在EnHabit获得了一个新的职位，价值约34万美元。最后，BCR Wealth Strategy LLC在第三季度购买了EnHabit的一个新头寸，价值约7.8万美元。95.55%的股票目前由机构投资者和对冲基金持有。
Enhabit Trading Down 5.7 %
安居降价5.7%
Shares of EHAB stock opened at $15.10 on Monday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.50 and a current ratio of 1.50. The company has a 50 day moving average price of $13.87 and a 200 day moving average price of $14.25. Enhabit, Inc. has a fifty-two week low of $11.65 and a fifty-two week high of $25.25.
周一，Ehab的股票开盘报15.10美元。该公司的负债权益比为0.63，速动比率为1.50，流动比率为1.50。该公司的50日移动均线价格为13.87美元，200日移动均线价格为14.25美元。EnHabit，Inc.的股价为52周低点11.65美元，52周高点25.25美元。
Insider Activity at Enhabit
EnHabit的内幕活动
Analyst Upgrades and Downgrades
分析师升级和下调评级
EHAB has been the topic of a number of analyst reports. UBS Group initiated coverage on shares of Enhabit in a research note on Thursday, December 8th. They set a "sell" rating and a $12.00 target price on the stock. CJS Securities began coverage on shares of Enhabit in a research note on Tuesday, December 13th. They set a "market perform" rating and a $18.00 target price on the stock. Oppenheimer began coverage on shares of Enhabit in a research note on Thursday, October 13th. They issued a "market perform" rating on the stock. Stifel Nicolaus began coverage on shares of Enhabit in a research note on Monday, December 5th. They issued a "buy" rating and a $17.00 price target on the stock. Finally, Credit Suisse Group reduced their price target on shares of Enhabit from $19.00 to $15.00 and set a "neutral" rating on the stock in a research note on Friday, November 4th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $16.43.
埃哈布一直是许多分析师报告的主题。瑞银集团在12月8日星期四的一份研究报告中启动了对EnHabit股票的报道。他们为该股设定了“卖出”评级和12.00美元的目标价。CJS证券于12月13日(星期二)在一份研究报告中开始报道EnHabit的股票。他们为该股设定了“市场表现”评级和18.00美元的目标价。奥本海默于10月13日星期四在一份研究报告中开始报道EnHabit的股票。他们对该股给予了“市场表现”的评级。Stifel Nicolaus于12月5日星期一在一份研究报告中开始报道EnHabit的股票。他们对该股给予了“买入”评级和17.00美元的目标价。最后，瑞士信贷集团在11月4日(星期五)的一份研究报告中将EnHabit的股票目标价从19.00美元下调至15.00美元，并将其股票评级定为“中性”。两名股票研究分析师对该股的评级为卖出，四名分析师给出了持有评级，两名分析师给出了该公司的买入评级。根据MarketBeat.com，该股目前的普遍评级为持有，平均目标价为16.43美元。
Enhabit Company Profile
安居公司简介
(Get Rating)
(获取评级)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
EnHabit，Inc.在美国提供家庭健康和临终关怀服务。它的家庭健康服务包括患者教育、疼痛管理、伤口护理和换药、心脏康复、输液治疗、药物管理和熟练的观察和评估服务；治疗慢性疾病和状况的做法，包括糖尿病、高血压、关节炎、阿尔茨海默病、低视力、椎管狭窄、帕金森病、骨质疏松症、复杂伤口护理和慢性疼痛，以及针对糖尿病、充血性心力衰竭、骨科术后手术或损伤和呼吸系统疾病的特定疾病计划；以及物理、职业和语言治疗师提供治疗服务。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Enhabit (EHAB)
- Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
- MarketBeat Week in Review – 1/30 – 2/3
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- 免费获取StockNews.com关于EnHabit的研究报告(Ehab)
- C3.ai人工智能产品套件是游戏变革者吗？
- 市场回顾周-1/30-2/3
- 细价股值得吗？你应该投资细价股吗？
- Zimmer Biomet盈利节节攀升，增长可能被计入价格
- 人工智能软件制造商EPAM号称科技板块涨幅最大
Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB – Get Rating).
想看看其他对冲基金持有埃哈布的股份吗？访问HoldingsChannel.com获取EnHabit，Inc.(纽约证券交易所代码：EHAB-GET Rating)的最新13F备案和内幕交易信息。
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
接受《居住者日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对EnHabit和相关公司的最新新闻和分析师评级的每日简要摘要。